These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 24369803)

  • 1. Urinary metabolomic changes as a predictive biomarker of asthma exacerbation.
    Loureiro CC; Duarte IF; Gomes J; Carrola J; Barros AS; Gil AM; Bousquet J; Bom AT; Rocha SM
    J Allergy Clin Immunol; 2014 Jan; 133(1):261-3.e1-5. PubMed ID: 24369803
    [No Abstract]   [Full Text] [Related]  

  • 2. Metabolomics of asthma.
    Amaral AF
    J Allergy Clin Immunol; 2014 May; 133(5):1497-9, 1499.e1. PubMed ID: 24679844
    [No Abstract]   [Full Text] [Related]  

  • 3. Reply: To PMID 24369803.
    Loureiro CC; Bousquet J; Todo Bom A; Rocha SM
    J Allergy Clin Immunol; 2014 May; 133(5):1499. PubMed ID: 24679847
    [No Abstract]   [Full Text] [Related]  

  • 4. Metabolomic profiling of asthma: diagnostic utility of urine nuclear magnetic resonance spectroscopy.
    Saude EJ; Skappak CD; Regush S; Cook K; Ben-Zvi A; Becker A; Moqbel R; Sykes BD; Rowe BH; Adamko DJ
    J Allergy Clin Immunol; 2011 Mar; 127(3):757-64.e1-6. PubMed ID: 21377043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative metabolomic profiling of serum and urine in DSS-induced ulcerative colitis of mice by (1)H NMR spectroscopy.
    Schicho R; Nazyrova A; Shaykhutdinov R; Duggan G; Vogel HJ; Storr M
    J Proteome Res; 2010 Dec; 9(12):6265-73. PubMed ID: 20886908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolomic biomarkers in a model of asthma exacerbation: urine nuclear magnetic resonance.
    Saude EJ; Obiefuna IP; Somorjai RL; Ajamian F; Skappak C; Ahmad T; Dolenko BK; Sykes BD; Moqbel R; Adamko DJ
    Am J Respir Crit Care Med; 2009 Jan; 179(1):25-34. PubMed ID: 18931331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Untargeted 1H-NMR metabolomics in CSF: toward a diagnostic biomarker for motor neuron disease.
    Blasco H; Nadal-Desbarats L; Pradat PF; Gordon PH; Antar C; Veyrat-Durebex C; Moreau C; Devos D; Mavel S; Emond P; Andres CR; Corcia P
    Neurology; 2014 Apr; 82(13):1167-74. PubMed ID: 24587475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mass spectrometry based metabolomic approaches in urinary biomarker study of women's cancers.
    Woo HM; Kim KM; Choi MH; Jung BH; Lee J; Kong G; Nam SJ; Kim S; Bai SW; Chung BC
    Clin Chim Acta; 2009 Feb; 400(1-2):63-9. PubMed ID: 19010317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The metabolic fate of red wine and grape juice polyphenols in humans assessed by metabolomics.
    van Dorsten FA; Grün CH; van Velzen EJ; Jacobs DM; Draijer R; van Duynhoven JP
    Mol Nutr Food Res; 2010 Jul; 54(7):897-908. PubMed ID: 20013882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. L-carnitine interference in gas chromatographic determination of total trimethylamine in urine: a novel assay method.
    Maccari F; Ferrari L; Pessotto P; Ramacci MT
    J Chromatogr; 1990 Oct; 532(1):124-9. PubMed ID: 2079525
    [No Abstract]   [Full Text] [Related]  

  • 11. Urinary metabolomic analysis for the identification of renal injury in patients with acute heart failure.
    Diercks DB; Owen K; Tolstikov V; Sutter M
    Acad Emerg Med; 2012 Jan; 19(1):18-23. PubMed ID: 22222043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary metabolomic profiling of asthmatics can be related to clinical characteristics.
    Loureiro CC; Oliveira AS; Santos M; Rudnitskaya A; Todo-Bom A; Bousquet J; Rocha SM
    Allergy; 2016 Sep; 71(9):1362-5. PubMed ID: 27188766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in urinary dinor dihydro F(2)-isoprostane metabolite concentrations, a marker of oxidative stress, during and following asthma exacerbations.
    Wu P; Roberts LJ; Shintani AK; Sheller JR; Minton PA; Higgins SB; Hartert TV
    Free Radic Res; 2007 Sep; 41(9):956-62. PubMed ID: 17729112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Asthma severity in childhood and metabolomic profiling of breath condensate.
    Carraro S; Giordano G; Reniero F; Carpi D; Stocchero M; Sterk PJ; Baraldi E
    Allergy; 2013 Jan; 68(1):110-7. PubMed ID: 23157191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultraperformance liquid chromatography-mass spectrometry based comprehensive metabolomics combined with pattern recognition and network analysis methods for characterization of metabolites and metabolic pathways from biological data sets.
    Zhang AH; Sun H; Han Y; Yan GL; Yuan Y; Song GC; Yuan XX; Xie N; Wang XJ
    Anal Chem; 2013 Aug; 85(15):7606-12. PubMed ID: 23845028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association of specific metabolites of lipid metabolism with markers of oxidative stress, inflammation and arterial stiffness in men with newly diagnosed type 2 diabetes.
    Ha CY; Kim JY; Paik JK; Kim OY; Paik YH; Lee EJ; Lee JH
    Clin Endocrinol (Oxf); 2012 May; 76(5):674-82. PubMed ID: 21958081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Searching for urine biomarkers of bladder cancer recurrence using a liquid chromatography-mass spectrometry and capillary electrophoresis-mass spectrometry metabolomics approach.
    Alberice JV; Amaral AF; Armitage EG; Lorente JA; Algaba F; Carrilho E; Márquez M; García A; Malats N; Barbas C
    J Chromatogr A; 2013 Nov; 1318():163-70. PubMed ID: 24139504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The metabolomics of asthma: novel diagnostic potential.
    Adamko DJ; Sykes BD; Rowe BH
    Chest; 2012 May; 141(5):1295-1302. PubMed ID: 22553262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Global metabolomics and targeted steroid profiling reveal that rifampin, a strong human PXR activator, alters endogenous urinary steroid markers.
    Kim B; Moon JY; Choi MH; Yang HH; Lee S; Lim KS; Yoon SH; Yu KS; Jang IJ; Cho JY
    J Proteome Res; 2013 Mar; 12(3):1359-68. PubMed ID: 23320515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary 8-hydroxydeoxyguanosine levels as a biomarker for progression of Parkinson disease.
    Sato S; Mizuno Y; Hattori N
    Neurology; 2005 Mar; 64(6):1081-3. PubMed ID: 15781836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.